This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1ynl
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Identification of Key residues of the NC6.8 Fab antibody fragment binding to synthetic sweeterners: Crystal structure of NC6.8 co-crystalized with high potency sweetener compound SC45647== | ==Identification of Key residues of the NC6.8 Fab antibody fragment binding to synthetic sweeterners: Crystal structure of NC6.8 co-crystalized with high potency sweetener compound SC45647== | ||
| - | <StructureSection load='1ynl' size='340' side='right' caption='[[1ynl]], [[Resolution|resolution]] 1.70Å' scene=''> | + | <StructureSection load='1ynl' size='340' side='right'caption='[[1ynl]], [[Resolution|resolution]] 1.70Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[1ynl]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[1ynl]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YNL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1YNL FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7Å</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NES:2-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-ETHANESULFONIC+ACID'>NES</scene></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1ynl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ynl OCA], [https://pdbe.org/1ynl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1ynl RCSB], [https://www.ebi.ac.uk/pdbsum/1ynl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1ynl ProSAT]</span></td></tr> |
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/A2P1G9_MOUSE A2P1G9_MOUSE] | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
| Line 27: | Line 29: | ||
</div> | </div> | ||
<div class="pdbe-citations 1ynl" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 1ynl" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Antibody 3D structures|Antibody 3D structures]] | ||
| + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
| + | *[[3D structures of non-human antibody|3D structures of non-human antibody]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Gokulan | + | [[Category: Mus musculus]] |
| - | [[Category: Khare | + | [[Category: Gokulan K]] |
| - | [[Category: Linthicum | + | [[Category: Khare S]] |
| - | [[Category: Ronning | + | [[Category: Linthicum SD]] |
| - | [[Category: Rupp | + | [[Category: Ronning DR]] |
| - | [[Category: Sacchettini | + | [[Category: Rupp B]] |
| - | + | [[Category: Sacchettini JC]] | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Identification of Key residues of the NC6.8 Fab antibody fragment binding to synthetic sweeterners: Crystal structure of NC6.8 co-crystalized with high potency sweetener compound SC45647
| |||||||||||

